{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T10:10:24Z","timestamp":1777111824811,"version":"3.51.4"},"reference-count":22,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2004,10,12]],"date-time":"2004-10-12T00:00:00Z","timestamp":1097539200000},"content-version":"vor","delay-in-days":11,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aliment Pharmacol Ther"],"published-print":{"date-parts":[[2004,10]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p><jats:bold>Background<\/jats:bold> :\u2002Budd\u2010Chiari syndrome is an uncommon cause of liver failure usually associated with an underlying hypercoagulable state.<\/jats:p><jats:p><jats:bold>Aim<\/jats:bold> :\u2002To evaluate current trends in management of Budd\u2010Chiari syndrome at our institution.<\/jats:p><jats:p><jats:bold>Methods<\/jats:bold> :\u2002Twenty\u2010two patients with Budd\u2010Chiari syndrome underwent transjugular intrahepatic porto\u2010systemic shunt, liver transplantation, or both in between 1992 and 2001. We analysed underlying diagnosis, medical therapy, complications, follow\u2010up and overall outcomes.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> Five patients (17%) presented with fulminant liver failure and 17 patients (83%) with new\u2010onset ascites or chronic liver disease. Seventeen patients (74%) underwent transjugular intrahepatic porto\u2010systemic shunt: improvement or stabilization occurred initially in 14 (82%), whereas the other three patients died within a month. At a mean 3\u2003years follow\u2010up eight patients (47%) continued to do well clinically and four have died (23.5%); seven have required transjugular intrahepatic porto\u2010systemic shunt revisions (mean 2.3 interventions), five have experienced transjugular intrahepatic porto\u2010systemic shunt occlusion managed with new transjugular intrahepatic porto\u2010systemic shunt placement and five patients underwent subsequent transplantation. Of the 10 patients who underwent liver transplantation, patient and graft survival are 80% at a mean 5.7\u2003years of follow\u2010up. No patient developed post\u2010transplant Budd\u2010Chiari syndrome.<\/jats:p><jats:p><jats:bold>Conclusions<\/jats:bold> :\u2002Transjugular intrahepatic porto\u2010systemic shunt is usually feasible in patients with Budd\u2010Chiari syndrome, and is best suited as a bridge to more timely liver transplantation. Long\u2010term success of transjugular intrahepatic porto\u2010systemic shunt is limited and usually requires revision, placement of a new shunt or liver transplantation. Liver transplantation with chronic anticoagulation offers excellent short\u2010 and medium\u2010term patient and graft survival. In our series, there was no recurrence of Budd\u2010Chiari syndrome after liver transplantation.<\/jats:p>","DOI":"10.1111\/j.1365-2036.2004.02190.x","type":"journal-article","created":{"date-parts":[[2004,10,12]],"date-time":"2004-10-12T12:51:53Z","timestamp":1097585513000},"page":"867-873","source":"Crossref","is-referenced-by-count":55,"title":["Treatment of Budd\u2010Chiari syndrome in a Liver Transplant Unit, the role of transjugular intrahepatic porto\u2010systemic shunt and liver transplantation"],"prefix":"10.1111","volume":"20","author":[{"given":"A.","family":"Attwell","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Ludkowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Nash","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Kugelmas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2004,10,12]]},"reference":[{"key":"e_1_2_8_2_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2002-23202"},{"key":"e_1_2_8_3_2","doi-asserted-by":"publisher","DOI":"10.1002\/bjs.1800820807"},{"key":"e_1_2_8_4_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000658-200104000-00007"},{"key":"e_1_2_8_5_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000658-199001000-00007"},{"key":"e_1_2_8_6_2","first-page":"3577","article-title":"Liver transplantation for Budd\u2010Chiari syndrome","volume":"26","author":"Knoop M","year":"1994","journal-title":"Transplant Proc"},{"key":"e_1_2_8_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(05)80249-1"},{"key":"e_1_2_8_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1051-0443(96)70818-7"},{"key":"e_1_2_8_9_2","first-page":"2304","article-title":"Use of TIPS as a bridge to transplantation in fulminant hepatic failure due to Budd\u2010Chiari syndrome","volume":"92","author":"Shresta R","year":"1997","journal-title":"Am J Gastroenterol"},{"key":"e_1_2_8_10_2","first-page":"603","article-title":"TIPS for Budd\u2010Chiari syndrome or portal vein thrombosis","volume":"94","author":"Ganger DR","year":"1999","journal-title":"Am J Fenterol"},{"key":"e_1_2_8_11_2","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2002.30274"},{"key":"e_1_2_8_12_2","doi-asserted-by":"publisher","DOI":"10.1001\/archsurg.1985.01390300007001"},{"key":"e_1_2_8_13_2","first-page":"1262","article-title":"Thrombolysis for acute Budd\u2010Chiari syndrome: case report and literature review","volume":"91","author":"Raju GS","year":"1996","journal-title":"Am J Gastroenterol"},{"key":"e_1_2_8_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0025-6196(12)61791-1"},{"key":"e_1_2_8_15_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.44.4.568"},{"key":"e_1_2_8_16_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000658-200009000-00006"},{"key":"e_1_2_8_17_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840210518"},{"key":"e_1_2_8_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9610(99)80095-6"},{"key":"e_1_2_8_19_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02088578"},{"key":"e_1_2_8_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(00)80405-5"},{"key":"e_1_2_8_21_2","first-page":"1447","article-title":"TIPS in combination with oral anticoagulation for Budd\u2010Chiari syndrome","volume":"49","author":"Seki S","year":"2001","journal-title":"Hepatogastroenterology"},{"key":"e_1_2_8_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1051-0443(99)70118-1"},{"key":"e_1_2_8_23_2","first-page":"204A","article-title":"Budd\u2010Chiari syndrome: long\u2010term results after treatment with TIPS","volume":"26","author":"Huber M","year":"1997","journal-title":"Hepatology"}],"container-title":["Alimentary Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2036.2004.02190.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2036.2004.02190.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2036.2004.02190.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T21:17:17Z","timestamp":1697231837000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2036.2004.02190.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,10]]},"references-count":22,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2004,10]]}},"alternative-id":["10.1111\/j.1365-2036.2004.02190.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2036.2004.02190.x","archive":["Portico"],"relation":{},"ISSN":["0269-2813","1365-2036"],"issn-type":[{"value":"0269-2813","type":"print"},{"value":"1365-2036","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,10]]}}}